financetom
Business
financetom
/
Business
/
Form 8.3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3
Mar 12, 2026 6:40 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

JUST GROUP PLC ( JTGPF )

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11-03-2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

0

0.00

(2) Cash-settled derivatives:

39,627,574

3.81

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

39,627,574

3.81

0

0.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (GBp)

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (GBp)

10p ordinary

equity swap

decreasing a long position

56

216.50

10p ordinary

equity swap

decreasing a long position

175099

217.00

10p ordinary

equity swap

decreasing a long position

6468

217.25

10p ordinary

equity swap

decreasing a long position

25

217.50

10p ordinary

equity swap

decreasing a short position

2950

217.00

10p ordinary

equity swap

decreasing a short position

725

217.25

10p ordinary

equity swap

increasing a long position

3361

216.50

10p ordinary

equity swap

increasing a long position

39391

217.00

10p ordinary

equity swap

increasing a long position

9364

217.25

10p ordinary

equity swap

increasing a long position

3301

217.50

10p ordinary

equity swap

increasing a short position

9

217.25

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBp)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit
(GBp)

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

0

0.00

(2) Cash-settled derivatives:

39,627,574

3.81

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

39,627,574

3.81

0

0.00

0

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

0

0.00

(2) Cash-settled derivatives:

39,627,574

3.81

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

39,627,574

3.81

0

0.00

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Qube Research & Technologies LTD

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vena Completes Acterys Acquisition to Accelerate Orchestrated Planning for the Microsoft Ecosystem
Vena Completes Acterys Acquisition to Accelerate Orchestrated Planning for the Microsoft Ecosystem
Mar 26, 2026
The combination connects AI-driven financial and operational planning, analytics and execution across Microsoft Excel and Power BI, removing decision latency for Microsoft-centric enterprises. TORONTO--(BUSINESS WIRE)-- Vena, the AI-powered Orchestrated Performance Management platform purpose-built to fully amplify the Microsoft technology ecosystem, today announced it has completed its acquisition of Acterys, the leading Microsoft Power BI–based operational planning and app development platform....
MARA to Repurchase Convertible Senior Notes; Shares Rise Pre-Bell
MARA to Repurchase Convertible Senior Notes; Shares Rise Pre-Bell
Mar 26, 2026
08:58 AM EDT, 03/26/2026 (MT Newswires) -- MARA (MARA) said Thursday it has signed repurchase agreements with certain holders of its outstanding 0% convertible senior notes due 2030 and 2031. The company intends to buy back about $367.5 million worth of the 2030 notes for about $322.9 million, and about $633.4 million worth of the 2031 notes for about $589.9...
MeiraGTx Says Radiation-Induced Xerostomia Treatment Gets FDA Breakthrough Therapy Designation
MeiraGTx Says Radiation-Induced Xerostomia Treatment Gets FDA Breakthrough Therapy Designation
Mar 26, 2026
08:58 AM EDT, 03/26/2026 (MT Newswires) -- MeiraGTx ( MGTX ) said Thursday that the US Food and Drug Administration granted Breakthrough Therapy Designation to AAV2-hAQP1 for the treatment of Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tract. The company said it will present three-year data for the AAV2-hAQP1 program as...
Synergy Sports Capital, Led by Former NFL Players Terrence C. Murphy Sr. and Reggie Bush, Acquires LOVB Salt Lake
Synergy Sports Capital, Led by Former NFL Players Terrence C. Murphy Sr. and Reggie Bush, Acquires LOVB Salt Lake
Mar 26, 2026
The move underscores the growing momentum behind Synergy Sports Capital’s inaugural fund and the surging interest in professional women’s volleyball in the U.S. LOS ANGELES & HOUSTON--(BUSINESS WIRE)-- League One Volleyball (LOVB) — the largest community in youth volleyball and the nation’s first professional league built from the club up — today announced that Synergy Sports Capital, the $150...
Copyright 2023-2026 - www.financetom.com All Rights Reserved